Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia

Patients with acute myeloid leukemia have a very poor prognosis related to a high rate of relapse and drug-related toxicity. The ability of leukemia stem cells (LSCs) to survive chemotherapy is primarily responsible for relapse, and eliminating LSCs is ultimately essential for cure. We developed nov...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nanomedicine
Egile Nagusiak: Lin, Tzu-yin, Zhu, Yanjun, Li, Yuanpei, Zhang, Hongyong, Ma, Ai-Hong, Long, Qilai, Keck, James, Lam, Kit S., Pan, Chong-xian, Jonas, Brian A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8237247/
https://ncbi.nlm.nih.gov/pubmed/31055076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2019.04.007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak